Boostrix Intramuscular and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Boostrix Intramuscular and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diphtheria toxoid / pertussis, acellular / tetanus toxoid
Brand name: Adacel, Boostrix
Synonyms: Boostrix Vaccine, Boostrix
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Boostrix Intramuscular-Insulin Glargine (U-100) Vials
- Boostrix Intramuscular-Insulin Glargine (U-300) Pens
- Boostrix Intramuscular-Insulin glargine and lixisenatide
- Boostrix Intramuscular-Insulin glargine and lixisenatide Subcutaneous
- Boostrix Intramuscular-Insulin glargine, recombinant Subcutaneous
- Boostrix Intramuscular-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Boroleum
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bortezomib
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bortezomib Intravenous
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bosentan
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bosentan Tablets
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bosentan Tablets for Oral Suspension